{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T06:08:48Z","timestamp":1774764528320,"version":"3.50.1"},"reference-count":49,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Egyptian Ministry of Higher Education"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.ijpharm.2016.07.016","type":"journal-article","created":{"date-parts":[[2016,7,12]],"date-time":"2016-07-12T23:37:36Z","timestamp":1468366656000},"page":"462-472","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Development and evaluation of viscosity-enhanced nanocarrier (VEN) for oral insulin delivery"],"prefix":"10.1016","volume":"511","author":[{"given":"Mariam","family":"Boushra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sozan","family":"Tous","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gihan","family":"Fetih","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Korzekwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David B.","family":"Lebo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui Yi","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ho Lun","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2016.07.016_bib0005","doi-asserted-by":"crossref","first-page":"435","DOI":"10.2147\/PPA.S32745","article-title":"Osteoporosis and type 2 diabetes mellitus: what do we know, and what we can do?","volume":"6","author":"Abdulameer","year":"2012","journal-title":"Patient Prefer Adherence"},{"key":"10.1016\/j.ijpharm.2016.07.016_bib0010","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2174\/157016311796799035","article-title":"Chitosan formulations as carriers for therapeutic proteins","volume":"8","author":"Andrade","year":"2011","journal-title":"Curr. Drug Discov. Technol."},{"key":"10.1016\/j.ijpharm.2016.07.016_bib0015","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.addr.2013.04.006","article-title":"Oral delivery of proteins by biodegradable nanoparticles","volume":"65","author":"Bakhru","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2016.07.016_bib0020","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ijpharm.2007.12.037","article-title":"Nanoparticles of quaternized chitosan derivatives as a carrier for colon delivery of insulin: ex vivo and in vivo studies","volume":"356","author":"Bayat","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2016.07.016_bib0025","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ejpb.2004.10.006","article-title":"Strategic approaches for overcoming peptide and protein instability within biodegradable nano- and microparticles","volume":"59","author":"Bilati","year":"2005","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2016.07.016_bib0030","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0169-409X(98)00075-1","article-title":"Oral insulin delivery","volume":"35","author":"Carino","year":"1999","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2016.07.016_bib0035","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1208\/s12249-010-9561-2","article-title":"Recent advancement of chitosan-based nanoparticles for oral controlled delivery of insulin and other therapeutic agents","volume":"12","author":"Chaudhury","year":"2011","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijpharm.2016.07.016_bib0040","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jconrel.2006.10.023","article-title":"Oral delivery of insulin associated to polymeric nanoparticles in diabetic rats","volume":"117","author":"Damge","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2016.07.016_bib0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpb.2014.02.005","article-title":"Nanotoxicology applied to solid lipid nanoparticles and nanostructured lipid carriers\u2fffa systematic review of in vitro data","volume":"87","author":"Doktorovova","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2016.07.016_bib0050","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1208\/s12249-011-9647-5","article-title":"Chitosan-sodium lauryl sulfate nanoparticles as a carrier system for the in vivo delivery of oral insulin","volume":"12","author":"Elsayed","year":"2011","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijpharm.2016.07.016_bib0055","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/B978-0-12-391860-4.00015-X","article-title":"Chitosan-coated solid lipid nanoparticles for insulin delivery","volume":"508","author":"Fonte","year":"2012","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.ijpharm.2016.07.016_bib0060","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1080\/02652040802390156","article-title":"Preparation of solid lipid nanoparticles from W\/O\/W emulsions: preliminary studies on insulin encapsulation","volume":"26","author":"Gallarate","year":"2009","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.ijpharm.2016.07.016_bib0065","first-page":"14","article-title":"Design of surface -modified lipid nanostructures for oral calcitonin delivery","volume":"10","author":"Garcia-Fuentes","year":"2005","journal-title":"Eur. Cells Mater."},{"key":"10.1016\/j.ijpharm.2016.07.016_bib0070","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0021-9673(95)00086-3","article-title":"Selective stability-indicating high-performance liquid chromatographic assay for recombinant human regular insulin","volume":"699","author":"Hoyer","year":"1995","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.ijpharm.2016.07.016_bib0075","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jconrel.2003.12.017","article-title":"Oral insulin delivery: the potential of thiolated chitosan-insulin tablets on non-diabetic rats","volume":"95","author":"Krauland","year":"2004","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2016.07.016_bib0080","series-title":"The American Psychiatric Publishing Textbook of Psychopharmacology","article-title":"Principles of pharmacokinetics and pharmacodynamics","author":"Devane","year":"2004"},{"key":"10.1016\/j.ijpharm.2016.07.016_bib0085","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1007\/s00894-014-2496-x","article-title":"A molecular simulation study of the protection of insulin bioactive structure by trehalose","volume":"20","author":"Li","year":"2014","journal-title":"J. Mol. Model."},{"key":"10.1016\/j.ijpharm.2016.07.016_bib0090","first-page":"62","article-title":"Solid lipid nanoparticles (SLN)\u2fffan alternative colloidal carrier system for controlled drug deliver","volume":"41","author":"M\u00fcller","year":"1995","journal-title":"Eur. J. Pharm. Biopharm"},{"key":"10.1016\/j.ijpharm.2016.07.016_bib0095","doi-asserted-by":"crossref","first-page":"313","DOI":"10.4155\/ppa.14.15","article-title":"Formulation strategies to improve oral peptide delivery","volume":"3","author":"Maher","year":"2014","journal-title":"Pharm. Patient Anal."},{"key":"10.1016\/j.ijpharm.2016.07.016_bib0100","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/S0142-9612(00)00039-9","article-title":"Oral peptide drug delivery: polymer-inhibitor conjugates protecting insulin from enzymatic degradation in vitro","volume":"21","author":"Marschutz","year":"2000","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijpharm.2016.07.016_bib0105","first-page":"595","article-title":"Lipid-based colloidal carriers for peptide and protein delivery\u2fffliposomes versus lipid nanoparticles","volume":"2","author":"Martins","year":"2007","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ijpharm.2016.07.016_bib0110","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0169-409X(01)00105-3","article-title":"Solid lipid nanoparticles: production, characterization and applications","volume":"47","author":"Mehnert","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2016.07.016_bib0115","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0168-3659(00)00352-7","article-title":"Stabilizing insulin-like growth factor-I in poly(d,l-lactide-co-glycolide) microspheres","volume":"70","author":"Meinel","year":"2001","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2016.07.016_bib0120","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0731-7085(03)00336-4","article-title":"A rapid and sensitive method for simultaneous determination of insulin and A21-desamido insulin by high-performance liquid chromatography","volume":"33","author":"Moslemi","year":"2003","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ijpharm.2016.07.016_bib0125","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ejpb.2014.04.014","article-title":"A new nanostructured carrier design including oil to enhance the pharmaceutical properties of retinoid therapy and its therapeutic effects on chemo-resistant ovarian cancer","volume":"88","author":"Narvekar","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2016.07.016_bib0130","series-title":"Lehninger Principles of Biochemistry","article-title":"Amino acids, peptides, and proteins","author":"Nelson","year":"2005"},{"key":"10.1016\/j.ijpharm.2016.07.016_bib0135","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1023\/A:1014818118224","article-title":"Why does PEG 400 co-encapsulation improve NGF stability and release from PLGA biodegradable microspheres?","volume":"16","author":"Pean","year":"1999","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2016.07.016_bib0140","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ejps.2006.04.014","article-title":"Nanoscale analysis of protein and peptide absorption: insulin absorption using complexation and pH-sensitive hydrogels as delivery vehicles","volume":"29","author":"Peppas","year":"2006","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2016.07.016_bib0145","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/B978-0-12-391860-4.00014-8","article-title":"Nanotechnology as a promising strategy for alternative routes of insulin delivery","volume":"508","author":"Reis","year":"2012","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.ijpharm.2016.07.016_bib0150","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ijpharm.2012.03.056","article-title":"Oral delivery of therapeutic protein\/peptide for diabetes\u2ffffuture perspectives","volume":"440","author":"Rekha","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2016.07.016_bib0155","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ijpharm.2013.02.030","article-title":"Approaches for enhancing oral bioavailability of peptides and proteins","volume":"447","author":"Renukuntla","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2016.07.016_bib0160","first-page":"743","article-title":"Oral insulin delivery by means of solid lipid nanoparticles","volume":"2","author":"Sarmento","year":"2007","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ijpharm.2016.07.016_bib0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3923\/tmr.2011.1.13","article-title":"Oral insulin delivery with various grades of HPMC on non-diabetic rats","volume":"6","author":"Singh","year":"2011","journal-title":"Trends Med. Res."},{"key":"10.1016\/j.ijpharm.2016.07.016_bib0170","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ijpharm.2009.09.018","article-title":"The influence of polymer architecture on the protective effect of novel comb shaped amphiphilic poly(allylamine) against in vitro enzymatic degradation of insulin\u2ffftowards oral insulin delivery","volume":"383","author":"Thompson","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2016.07.016_bib0175","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1007\/s11095-010-0345-x","article-title":"Uptake and transport of novel amphiphilic polyelectrolyte-insulin nanocomplexes by Caco-2 cells\u2ffftowards oral insulin","volume":"28","author":"Thompson","year":"2011","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2016.07.016_bib0180","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1007\/s12325-012-0034-8","article-title":"Evolution of insulin development: focus on key parameters","volume":"29","author":"Tibaldi","year":"2012","journal-title":"Adv. Ther."},{"key":"10.1016\/j.ijpharm.2016.07.016_bib0185","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0378-5173(03)00055-3","article-title":"Insulin containing polyethylenimine-dextran sulfate nanoparticles","volume":"255","author":"Tiyaboonchai","year":"2003","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2016.07.016_bib0190","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1080\/01932691.2010.488497","article-title":"Insulin-loaded SLN prepared with the emulsion dilutiontechnique: in vivo tracking of nanoparticles after oral administration to rats","volume":"32","author":"Trotta","year":"2011","journal-title":"J. Dispersion Sci. Technol."},{"key":"10.1016\/j.ijpharm.2016.07.016_bib0195","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1002\/jps.20969","article-title":"Development and characterization of chitosan succinate microspheres for the improved oral bioavailability of insulin","volume":"96","author":"Ubaidulla","year":"2007","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2016.07.016_bib0200","first-page":"375","article-title":"Preparation, characterization and physico-chemical properties of solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC): their benefits as colloidal drug carrier systems","volume":"61","author":"Uner","year":"2006","journal-title":"Pharmazie"},{"key":"10.1016\/j.ijpharm.2016.07.016_bib0205","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1016\/j.biomaterials.2004.07.050","article-title":"Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs","volume":"26","author":"Win","year":"2005","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijpharm.2016.07.016_bib0210","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2165\/00063030-200822040-00002","article-title":"Strategies toward the improved oral delivery of insulin nanoparticles via gastrointestinal uptake and translocation","volume":"22","author":"Woitiski","year":"2008","journal-title":"BioDrugs"},{"key":"10.1016\/j.ijpharm.2016.07.016_bib0215","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0378-5173(03)00071-1","article-title":"Stabilisation and determination of the biological activity of L-asparaginase in poly(D,L-lactide-co-glycolide) nanospheres","volume":"256","author":"Wolf","year":"2003","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2016.07.016_bib0220","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1248\/cpb.58.1195","article-title":"Preparation of gel-core-solid lipid nanoparticle: a novel way to improve the encapsulation of protein and peptide","volume":"58","author":"Yang","year":"2010","journal-title":"Chem. Pharm. Bull. (Tokyo)"},{"key":"10.1016\/j.ijpharm.2016.07.016_bib0225","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.addr.2012.10.007","article-title":"Nanoparticles for oral delivery: targeted nanoparticles with peptidic ligands for oral protein delivery","volume":"65","author":"Yun","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2016.07.016_bib0230","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ijpharm.2006.07.026","article-title":"Lectin-modified solid lipid nanoparticles as carriers for oral administration of insulin","volume":"327","author":"Zhang","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2016.07.016_bib0235","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejpb.2010.09.016","article-title":"Preparation and evaluation of alginate-chitosan microspheres for oral delivery of insulin","volume":"77","author":"Zhang","year":"2011","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2016.07.016_bib0240","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.ejps.2012.01.002","article-title":"Preparation and characterization of insulin-loaded bioadhesive PLGA nanoparticles for oral administration","volume":"45","author":"Zhang","year":"2012","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2016.07.016_bib0245","first-page":"574","article-title":"Novel solid lipid nanoparticles as carriers for oral administration of insulin","volume":"64","author":"Zhang","year":"2009","journal-title":"Pharmazie"}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517316306469?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517316306469?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T15:54:35Z","timestamp":1536594875000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517316306469"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S0378517316306469"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2016.07.016","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and evaluation of viscosity-enhanced nanocarrier (VEN) for oral insulin delivery","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2016.07.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}